Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Valeant Rejected Joint Takeover Approach From Takeda, TPG
Valeant Rejected Joint Takeover Approach From Takeda, TPG
Valeant Pharmaceuticals International Inc.
Zambon Launches Xadago® (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Zambon Launches Xadago® (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Zambon S.
French drugmaker Sanofi to step up push into China
French drugmaker Sanofi to step up push into China
Sanofi (SASY.
Janssen’s Darzalex gets conditional European Commission approval to treat multiple myeloma
Janssen’s Darzalex gets conditional European Commission approval to treat multiple myeloma
Janssen said the European Commission (EC) conditionally approved its biologic Darzalex (daratumumab) to treat blood cancer.
Sanofi Moves to Replace Medivation Board
Sanofi Moves to Replace Medivation Board
PARIS—French pharmaceutical company Sanofi SA Wednesday stepped up pressure on U.
FDA panel recommends approval of Novo Nordisk diabetes drug
FDA panel recommends approval of Novo Nordisk diabetes drug
A U.
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
SEOUL (Reuters) - South Korean biosimilars maker Samsung Bioepis Co Ltd said on Tuesday it has applied to the U.
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
AstraZeneca and its global biologics research and development arm, MedImmune, will provide an update on their extensive oncology pipeline at the annual meeting of the American Society of Clinical Onco...
FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma
FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma
May 18, 2016 -- The U.
Deals this week: Trianni, ANI Pharma, Merus Labs
Deals this week: Trianni, ANI Pharma, Merus Labs
Trianni and Evotec AG have entered a co-development agreement to develop Evotec's existing drug discovery platforms, as well as new projects.
Osaka University concludes a comprehensive collaboration agreement with Chugai Pharmaceutical Co., Ltd.
Osaka University concludes a comprehensive collaboration agreement with Chugai Pharmaceutical Co., Ltd.
Osaka University and Chugai Pharmaceutical Co.
Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
JERUSALEM, May 18, 2016 /PRNewswire/ — Oramed Pharmaceuticals Inc.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand